Advertisement
ARDX Forex Aktualności
Ardelyx Says Japan Approves Tenapanor For Hyperphosphatemia
Biopharmaceutical company Ardelyx, Inc. (ARDX) announced Monday that its collaboration partner in Japan, Kyowa Kirin Co., Ltd., has received approval from the Japanese Ministry of Health, Labour and Welfare (MHLW) for the New Drug Application (NDA) for tenapanor for the improvement of hyperphosphatemia in adult patients with chronic kidney disease (CKD) on dialysis. Tenapanor will be marketed with the brand name PHOZEVEL in Japan.
RTTNews
|
629 dni temu
Ardelyx To Receive Up To $20 Mln Financing Deal With HealthCare Royalty Partners
Biopharmaceutical company Ardelyx, Inc. (ARDX) announced Thursday that the company may receive up to $20 million from HealthCare Royalty Partners from the sale of its future royalties and sales milestones from Kyowa Kirin Co., Ltd., its collaboration partner in Japan for the commercialization of tenapanor for hyperphosphatemia.
RTTNews
|
1081 dni temu
